.png)
Large Medtech
Health Economics and Outcomes Research, Market Access
Launched
Obesity / Bariatric Disease
Subscribe to our newsletter to receive the latest case studies.
Large Medtech
Health Economics and Outcomes Research, Market Access
Launched
Obesity / Bariatric Disease
A large medtech company had launched a novel endoscopic treatment for obesity and needed to secure coverage across U.S. payers.
While clinical evidence was available, payers raised questions around burden, outcomes, and how the technology compared to existing treatment options.
The client engaged Alkemi to develop a clear, credible payer value story that addressed objections and supported U.S. coverage discussions.
1. Conducted targeted literature and payer policy reviews to assess evidence supporting key value domains.
2. Developed payer-relevant value messages and mapped available clinical and economic evidence to support those messages.
3. Coordinated iterative reviews with cross-functional stakeholders to refine positioning and ensure alignment.
4. Recommended and aligned on a dossier format that highlighted differentiated device features and outcomes.
Equip teams with a payer-ready value narrative that withstands scrutiny.
"I appreciate your team's eagle eye, and I very much trust your judgement." - HEOR Lead
Delivered a draft payer dossier in four weeks to support timely U.S. access discussions.
Cross-functional teams aligned on how the technology should be positioned to payers.
Clear, evidence-based messaging supported more confident coverage discussions.